| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/02/2008 | EP1905762A1 Pyrazolone derivative |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/02/2008 | EP1905452A1 Agent for prevention or treatment of glaucoma |
| 04/02/2008 | EP1905450A1 Pharmaceutical composition containing ppar gamma agonist |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905431A1 Pravastatin pharmaceutical formulations and methods of their use |
| 04/02/2008 | EP1904444A2 Fluvastatin sodium novel forms and preparation therof |
| 04/02/2008 | EP1904087A2 Use of mas g-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 04/02/2008 | EP1903888A1 Prevention and treatment of osteochondrosis in animals and humans |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1311260B1 Lipase inhibitors to treat dyspepsia |
| 04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
| 04/02/2008 | EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use |
| 04/02/2008 | EP0822830B1 Human anti-IL-8 antibodies, derived from immunized xenomice |
| 04/02/2008 | EP0815245B1 Bioactive il-12 fusion proteins |
| 04/02/2008 | CN101155600A Radiotherapy enhancer |
| 04/02/2008 | CN101153042A Thienopyrimidine compound and use of the same |
| 04/02/2008 | CN101152538A Traditional Chinese medicine for treating thyroid tumor |
| 04/02/2008 | CN101152536A Traditional Chinese medicine for treating Hashimoto's thyroiditis |
| 04/02/2008 | CN101152535A Traditional Chinese medicine for treating subacute thyroiditis |
| 04/02/2008 | CN101152500A Chinese medicine for curing appendicitis and method for preparing the same |
| 04/02/2008 | CN101152454A Chinese medicinal materials for treating dizziness |
| 04/02/2008 | CN101152425A Traditional Chinese medicine for treating thyroid benign goitre |
| 04/02/2008 | CN101152400A Traditional Chinese medicine for treating simple goiter |
| 04/02/2008 | CN101152399A Traditional Chinese medicine for treating struma |
| 04/02/2008 | CN101152323A Traditional Chinese medicine for treating children's hernia |
| 04/02/2008 | CN101152299A Traditional Chinese medicine for treating goiter and tumor |
| 04/02/2008 | CN101152295A Aromatic essential oil capable of excitateding vitality and enjoying oneself, and uses of the same |
| 04/02/2008 | CN101152280A Traditional Chinese medicine for treating children's night cry in suspense |
| 04/02/2008 | CN101152271A Traditional Chinese medicine for treating children's night cry of stagnated heat of heart and gall |
| 04/02/2008 | CN101152249A Traditional Chinese medicine for treating filariasis spargosis |
| 04/02/2008 | CN101152229A Notoginseng total saponin orally disintegrating tablets and method for preparing the same |
| 04/02/2008 | CN101152228A Permeation pump controlled release formulation, preparing method and use of the same |
| 04/02/2008 | CN101152211A Dachengqi tang animal blood plasma freeze-dried powder and method for preparing the same |
| 04/02/2008 | CN101152179A Application of isoniazide as histone deacetylase inhibitors |
| 04/02/2008 | CN101152151A Vascellum esoderma growth factor sustained-release corpuscle and method for preparing the same |
| 04/02/2008 | CN101152145A Sugar-free type armillarisin oral solution |
| 04/02/2008 | CN100378214C Probiotic bacterium: lactobacillus fermentum |
| 04/02/2008 | CN100378108C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2008 | CN100378107C Oxazolo-and-furopyrimidines and their use as medicaments against tumors |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378095C Substituted indoles as alpha-1 agonists |
| 04/02/2008 | CN100378087C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/02/2008 | CN100377743C Process for the preparation of a nutrient formulation |
| 04/02/2008 | CN100377742C Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 04/02/2008 | CN100377714C Application of steroidal sapogenins and their derivatives in medicine preparation |
| 04/02/2008 | CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 04/02/2008 | CN100377710C Aromatase inhibition to enhance assisted reproduction |
| 04/02/2008 | CN100377706C A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 04/02/2008 | CN100377666C Process for preparing micrometer ginseng, tortoise, pearl and pollen wine for nourishing yin and removing fatigue |
| 04/02/2008 | CN100377665C Process for preparing micrometer ginseng, tortoise, pearl and pollen oral liquor for nourishing yin, removing fatigue and supplementing calcium |
| 04/02/2008 | CN100377664C Process for preparing micrometer ginseng, tortoise pearl pollen granules, capsule and tablet for nourishing yin, removing fatigue and supplementing granule calcium |
| 04/02/2008 | CN100377663C Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen oral liquor for strengthening yang, removing fatigue and supplementing calcium |
| 04/02/2008 | CN100377662C Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen calcium supplement granule capsule and tablet for strengthening yang, removing fatigue and supplementing calcium |
| 04/02/2008 | CN100377661C Process for preparing micrometer sugared shentiandiyinluyi, kidney invigorating and fatigue reducing wine |
| 04/02/2008 | CN100377656C Method for preparing soymilk contg. micron ginseng, antler. pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 04/02/2008 | CN100377654C Method for preparing sour soymilk containing micron ginseng, antler pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 04/01/2008 | US7351875 Using recombinant rodent which expresses Fc gamma RIIa receptor as tool in identifying modulators for treatment and prevention of arthritic and autoimmune disorders |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351813 Expression vector coding heterologous protein for use in human therapeutics; for treatment of blood nd liver disorders |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351736 Therapeutic compositions (II) |
| 04/01/2008 | US7351734 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/01/2008 | US7351732 Serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists; neuroprotective agents; cerebral damage due to traumatic or ischemic stroke; 2-[4-[(Chroman-2-yl)methylamine]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazol |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| 04/01/2008 | US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 04/01/2008 | US7351707 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351699 Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent |
| 04/01/2008 | US7351697 Tumor-specific vector for gene therapy |
| 04/01/2008 | US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 04/01/2008 | US7351555 Expression vector comprising nucleotide sequences coding cytokine receptor (Zcytor16) for use as antagonist tool of interleukin-10 related t-cell derived inducible factor in diagnosis, treatment and prevention of cell proliferative and inflammatory disorders |
| 04/01/2008 | US7351531 Molecules capable of binding to telomere and the like and method with the use of the same |
| 04/01/2008 | US7351415 Gene therapy; vaccines; storage stability; mixture containing viruses |
| 04/01/2008 | US7351410 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/01/2008 | US7350331 Method for producing metabolites from plants cultivated in soil-less medium |
| 04/01/2008 | CA2471952C Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 04/01/2008 | CA2371896C Method of increasing the content of flavonoids and phenolic substances in plants |
| 04/01/2008 | CA2356157C Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 04/01/2008 | CA2343299C Method for preventing or delaying catheter-based revascularization |
| 04/01/2008 | CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same |
| 04/01/2008 | CA2294099C Absorption of minerals |
| 04/01/2008 | CA2291074C Composition and method for enhancing transport across biological membranes |
| 03/27/2008 | WO2008036841A2 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference |
| 03/27/2008 | WO2008036825A2 Duplex oligonucleotide complexes and methods for gene silencing by rna interference |
| 03/27/2008 | WO2008035823A1 Cell death inhibitor |
| 03/27/2008 | WO2008035629A1 Pyrazolopyrimidine derivative |
| 03/27/2008 | WO2008035583A1 Moisturizing agent, cell-activating agent, antioxidant agent, protease activity enhancing agent, anti-aging agent, skin-whitening agent, anti-inflammatory agent, and neutral fat accumulation-inhibiting agent |
| 03/27/2008 | WO2008035566A1 Cell activator, collagen production promoter, collagenase activity inhibitor, melanin formation inhibitor, antioxidant agent, antiinflammatory agent, fat accumilation inhibitor, external preparation for skin, and food |